School of Philosophy, Psychology, and Language Sciences, The University of Edinburgh, Edinburgh, UK.
Euan MacDonald Centre for Motor Neuron Disease Research, The University of Edinburgh, Edinburgh, UK.
J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):316-324. doi: 10.1136/jnnp-2023-331697.
Cognitive and behavioural dysfunction may occur in people with motor neuron disease (MND), with some studies suggesting an association with the repeat expansion. Their onset and progression, however, is poorly understood. We explored how cognition and behaviour change over time, and whether demographic, clinical and genetic factors impact these changes.
Participants with MND were recruited through the Phenotype-Genotype-Biomarker study. Every 3-6 months, the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) was used to assess amyotrophic lateral sclerosis (ALS) specific (executive functioning, verbal fluency, language) and ALS non-specific (memory, visuospatial) functions. Informants reported on behaviour symptoms via semi-structured interview.
Participants with neuropsychological data at ≥3 visits were included (n=237, mean age=59, 60% male), of which 18 (8%) were positive. Baseline cognitive impairment was apparent in 18 (8%), typically in ALS specific domains, and associated with lower education, but not status. Cognition, on average, remained stable over time, with two exceptions: (1) carriers declined in all ECAS domains, (2) 8%-9% of participants with baseline cognitive impairment further declined, primarily in the ALS non-specific domain, which was associated with less education. Behavioural symptoms were uncommon.
In this study, cognitive dysfunction was less common than previously reported and remained stable over time for most. However, cognition declines longitudinally in a small subset, which is not entirely related to status. Our findings raise questions about the timing of cognitive impairment in MND, and whether it arises during early clinically manifest disease or even prior to motor manifestations.
运动神经元病(MND)患者可能出现认知和行为功能障碍,一些研究表明这与重复扩展有关。然而,其发病和进展情况仍不清楚。我们探讨了认知和行为如何随时间变化,以及人口统计学、临床和遗传因素是否会影响这些变化。
通过表型-基因型-生物标志物研究招募 MND 患者。每 3-6 个月,使用爱丁堡认知和行为 ALS 筛查(ECAS)评估肌萎缩侧索硬化(ALS)特异性(执行功能、语言流畅性、语言)和 ALS 非特异性(记忆、视空间)功能。通过半结构化访谈,告知者报告行为症状。
纳入了至少有 3 次就诊时神经心理学数据的参与者(n=237,平均年龄 59 岁,60%为男性),其中 18 例(8%)为阳性。基线认知障碍在 18 例(8%)中明显,主要在 ALS 特异性领域,与较低的教育程度相关,但与 状态无关。认知功能平均上随时间保持稳定,有两个例外:(1)携带者在所有 ECAS 领域均下降,(2)8%-9%的基线认知障碍患者进一步下降,主要在 ALS 非特异性领域,这与教育程度较低有关。行为症状并不常见。
在这项研究中,认知功能障碍比之前报道的要少见,并且大多数患者在随访期间保持稳定。然而,一小部分患者的认知功能会随时间纵向下降,这并不完全与 状态有关。我们的发现提出了关于 MND 中认知障碍发生时间的问题,以及它是否发生在早期临床明显疾病期间,甚至在运动表现之前。